Marc Becker
2016 - CRISPR Therapeutics AG
In 2016, Marc Becker earned a total compensation of $2.2M as Chief Financial Officer at CRISPR Therapeutics AG.
Compensation breakdown
| Bonus | $101,500 |
|---|---|
| Non-Equity Incentive Plan | $114,701 |
| Option Awards | $1,692,641 |
| Salary | $291,783 |
| Total | $2,200,625 |
Becker received $1.7M in option awards, accounting for 77% of the total pay in 2016.
Becker also received $101.5K in bonus, $114.7K in non-equity incentive plan and $291.8K in salary.
Rankings
In 2016, Marc Becker's compensation ranked 4,458th out of 14,075 executives tracked by ExecPay. In other words, Becker earned more than 68.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,458 out of 14,075 | 68th |
Division Manufacturing | 1,569 out of 5,489 | 71st |
Major group Chemicals And Allied Products | 476 out of 1,895 | 75th |
Industry group Drugs | 348 out of 1,538 | 77th |
Industry Biological Products, Except Diagnostic Substances | 66 out of 279 | 76th |
Source: SEC filing on April 18, 2017.
Becker's colleagues
We found three more compensation records of executives who worked with Marc Becker at CRISPR Therapeutics AG in 2016.